Cargando…

Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis

OBJECTIVE: In this cohort of individuals with and without multiple sclerosis (MS), we illustrate some of the novel approaches that smartphones provide to monitor patients with chronic neurologic disorders in their natural setting. METHODS: Thirty-eight participant pairs (MS and cohabitant) aged 18–5...

Descripción completa

Detalles Bibliográficos
Autores principales: Bove, Riley, White, Charles C., Giovannoni, Gavin, Glanz, Bonnie, Golubchikov, Victor, Hujol, Johnny, Jennings, Charles, Langdon, Dawn, Lee, Michelle, Legedza, Anna, Paskavitz, James, Prasad, Sashank, Richert, John, Robbins, Allison, Roberts, Susan, Weiner, Howard, Ramachandran, Ravi, Botfield, Martyn, De Jager, Philip L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608760/
https://www.ncbi.nlm.nih.gov/pubmed/26516627
http://dx.doi.org/10.1212/NXI.0000000000000162
_version_ 1782395711693783040
author Bove, Riley
White, Charles C.
Giovannoni, Gavin
Glanz, Bonnie
Golubchikov, Victor
Hujol, Johnny
Jennings, Charles
Langdon, Dawn
Lee, Michelle
Legedza, Anna
Paskavitz, James
Prasad, Sashank
Richert, John
Robbins, Allison
Roberts, Susan
Weiner, Howard
Ramachandran, Ravi
Botfield, Martyn
De Jager, Philip L.
author_facet Bove, Riley
White, Charles C.
Giovannoni, Gavin
Glanz, Bonnie
Golubchikov, Victor
Hujol, Johnny
Jennings, Charles
Langdon, Dawn
Lee, Michelle
Legedza, Anna
Paskavitz, James
Prasad, Sashank
Richert, John
Robbins, Allison
Roberts, Susan
Weiner, Howard
Ramachandran, Ravi
Botfield, Martyn
De Jager, Philip L.
author_sort Bove, Riley
collection PubMed
description OBJECTIVE: In this cohort of individuals with and without multiple sclerosis (MS), we illustrate some of the novel approaches that smartphones provide to monitor patients with chronic neurologic disorders in their natural setting. METHODS: Thirty-eight participant pairs (MS and cohabitant) aged 18–55 years participated in the study. Each participant received an Android HTC Sensation 4G smartphone containing a custom application suite of 19 tests capturing participant performance and patient-reported outcomes (PROs). Over 1 year, participants were prompted daily to complete one assigned test. RESULTS: A total of 22 patients with MS and 17 cohabitants completed the entire study. Among patients with MS, low scores on PROs relating to mental and visual function were associated with dropout (p < 0.05). We illustrate several novel features of a smartphone platform. First, fluctuations in MS outcomes (e.g., fatigue) were assessed against an individual's ambient environment by linking responses to meteorological data. Second, both response accuracy and speed for the Ishihara color vision test were captured, highlighting the benefits of both active and passive data collection. Third, a new trait, a person-specific learning curve in neuropsychological testing, was identified using spline analysis. Finally, averaging repeated measures over the study yielded the most robust correlation matrix of the different outcome measures. CONCLUSIONS: We report the feasibility of, and barriers to, deploying a smartphone platform to gather useful passive and active performance data at high frequency in an unstructured manner in the field. A smartphone platform may therefore enable large-scale naturalistic studies of patients with MS or other neurologic diseases.
format Online
Article
Text
id pubmed-4608760
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-46087602015-10-29 Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis Bove, Riley White, Charles C. Giovannoni, Gavin Glanz, Bonnie Golubchikov, Victor Hujol, Johnny Jennings, Charles Langdon, Dawn Lee, Michelle Legedza, Anna Paskavitz, James Prasad, Sashank Richert, John Robbins, Allison Roberts, Susan Weiner, Howard Ramachandran, Ravi Botfield, Martyn De Jager, Philip L. Neurol Neuroimmunol Neuroinflamm Article OBJECTIVE: In this cohort of individuals with and without multiple sclerosis (MS), we illustrate some of the novel approaches that smartphones provide to monitor patients with chronic neurologic disorders in their natural setting. METHODS: Thirty-eight participant pairs (MS and cohabitant) aged 18–55 years participated in the study. Each participant received an Android HTC Sensation 4G smartphone containing a custom application suite of 19 tests capturing participant performance and patient-reported outcomes (PROs). Over 1 year, participants were prompted daily to complete one assigned test. RESULTS: A total of 22 patients with MS and 17 cohabitants completed the entire study. Among patients with MS, low scores on PROs relating to mental and visual function were associated with dropout (p < 0.05). We illustrate several novel features of a smartphone platform. First, fluctuations in MS outcomes (e.g., fatigue) were assessed against an individual's ambient environment by linking responses to meteorological data. Second, both response accuracy and speed for the Ishihara color vision test were captured, highlighting the benefits of both active and passive data collection. Third, a new trait, a person-specific learning curve in neuropsychological testing, was identified using spline analysis. Finally, averaging repeated measures over the study yielded the most robust correlation matrix of the different outcome measures. CONCLUSIONS: We report the feasibility of, and barriers to, deploying a smartphone platform to gather useful passive and active performance data at high frequency in an unstructured manner in the field. A smartphone platform may therefore enable large-scale naturalistic studies of patients with MS or other neurologic diseases. Lippincott Williams & Wilkins 2015-10-15 /pmc/articles/PMC4608760/ /pubmed/26516627 http://dx.doi.org/10.1212/NXI.0000000000000162 Text en © 2015 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Article
Bove, Riley
White, Charles C.
Giovannoni, Gavin
Glanz, Bonnie
Golubchikov, Victor
Hujol, Johnny
Jennings, Charles
Langdon, Dawn
Lee, Michelle
Legedza, Anna
Paskavitz, James
Prasad, Sashank
Richert, John
Robbins, Allison
Roberts, Susan
Weiner, Howard
Ramachandran, Ravi
Botfield, Martyn
De Jager, Philip L.
Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis
title Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis
title_full Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis
title_fullStr Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis
title_full_unstemmed Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis
title_short Evaluating more naturalistic outcome measures: A 1-year smartphone study in multiple sclerosis
title_sort evaluating more naturalistic outcome measures: a 1-year smartphone study in multiple sclerosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608760/
https://www.ncbi.nlm.nih.gov/pubmed/26516627
http://dx.doi.org/10.1212/NXI.0000000000000162
work_keys_str_mv AT boveriley evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis
AT whitecharlesc evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis
AT giovannonigavin evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis
AT glanzbonnie evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis
AT golubchikovvictor evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis
AT hujoljohnny evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis
AT jenningscharles evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis
AT langdondawn evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis
AT leemichelle evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis
AT legedzaanna evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis
AT paskavitzjames evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis
AT prasadsashank evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis
AT richertjohn evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis
AT robbinsallison evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis
AT robertssusan evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis
AT weinerhoward evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis
AT ramachandranravi evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis
AT botfieldmartyn evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis
AT dejagerphilipl evaluatingmorenaturalisticoutcomemeasuresa1yearsmartphonestudyinmultiplesclerosis